Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sutro Biopharma Announces Interim Data on STRO-002 Study for Ovarian Cancer

americanpharmaceuticalreviewDecember 24, 2020

Tag: Sutro Biopharma , STRO-002 , ovarian cancer , FolRα

PharmaSources Customer Service